Life Sciences
How life sciences legal teams prepare for a technology-driven future
New health technology brings new data, and new responsibilities for legal teams.
Advances in health technology create new data flows for life sciences companies.
New data privacy considerations
Patient data from devices and apps raises new questions.
Design with privacy and security in mind
Build protections into products.
Make trust a policy
Be transparent about data use.
Four things pharmaceutical companies should do now
Map data flows, update policies, train teams and engage regulators.
Summary
Legal teams that prepare now will enable innovation safely.
Keep reading
Related articles
Article
How biopharma can get the right mix of people and technology for launch success
Biopharma companies need an end-to-end, AI-enabled launch strategy to succeed in a challenging market.
Article
How next-generation CRM will reshape the life sciences commercial model
Customer relationship management in life sciences must move from static maps to real-time navigation.
Article
What pharma supply chain transformation means for tax
Companies building resilient supply chains should involve tax and transfer pricing teams early.